{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:37:18Z","timestamp":1788025038468,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.neurol.2023.01.731","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T15:11:55Z","timestamp":1691421115000},"page":"1008-1019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy, safety and tolerability of high caloric diet in amyotrophic lateral sclerosis patients: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5756-7321","authenticated-orcid":false,"given":"M.B.","family":"Prado Jr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Pedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J.B.","family":"Adiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2023.01.731_bib0125","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/CON.0000000000000535","article-title":"Diagnosis and clinical management of amyotrophic lateral sclerosis and other motor neuron disorders","volume":"23","author":"Goutman","year":"2017","journal-title":"Continuum Lifelong Learn Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2023.01.731_bib0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1049909115610078","article-title":"End-of-life care of patients with amyotrophic lateral sclerosis and other non-malignant diseases","volume":"34","author":"Tiirola","year":"2017","journal-title":"Am J Hospice Palliat Med"},{"issue":"10","key":"10.1016\/j.neurol.2023.01.731_bib0135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14737175.2016.1197774","article-title":"Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis","volume":"16","author":"Noto","year":"2016","journal-title":"Expert Rev Neurother"},{"issue":"10","key":"10.1016\/j.neurol.2023.01.731_bib0140","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.neurol.2023.01.731_bib0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2003715","article-title":"Phase 1-2 trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"383","author":"Miller","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2023.01.731_bib0150","series-title":"Perampanel for amyotrophic lateral sclerosis: a systematic review and meta-analysis. Vol. 43, neurological sciences","first-page":"889","author":"Turalde","year":"2022"},{"issue":"4","key":"10.1016\/j.neurol.2023.01.731_bib0155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ncl.2015.07.009","article-title":"Potential environmental factors in amyotrophic lateral sclerosis","volume":"33","author":"Oskarsson","year":"2015","journal-title":"Neurol Clin"},{"issue":"3","key":"10.1016\/j.neurol.2023.01.731_bib0160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/0884533613476554","article-title":"Nutrition management of amyotrophic lateral sclerosis","volume":"28","author":"Greenwood","year":"2013","journal-title":"Nutr Clin Pract"},{"issue":"2","key":"10.1016\/j.neurol.2023.01.731_bib0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.chest.2018.06.035","article-title":"Respiratory failure in amyotrophic lateral sclerosis","volume":"155","author":"Niedermeyer","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.neurol.2023.01.731_bib0170","doi-asserted-by":"crossref","first-page":"117257","DOI":"10.1016\/j.jns.2020.117257","article-title":"Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects","volume":"420","author":"Fayemendy","year":"2021","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.neurol.2023.01.731_bib0175","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/WNL.53.5.1059","article-title":"Nutritional status is a prognostic factor for survival in ALS patients","volume":"53","author":"Desport","year":"1999","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2023.01.731_bib0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2008.12.027","article-title":"Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?","volume":"279","author":"Vaisman","year":"2009","journal-title":"J Neurol Sci"},{"issue":"11","key":"10.1016\/j.neurol.2023.01.731_bib0185","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.3390\/nu13113704","article-title":"Body fat percentage and availability of oral food intake: prognostic factors and implications for nutrition in amyotrophic lateral sclerosis","volume":"13","author":"Park","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.neurol.2023.01.731_bib0190","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/0883073813488669","article-title":"High-fat and ketogenic diets in amyotrophic lateral sclerosis","volume":"28","author":"Paganoni","year":"2013","journal-title":"J Child Neurol"},{"issue":"12","key":"10.1016\/j.neurol.2023.01.731_bib0195","doi-asserted-by":"crossref","DOI":"10.3390\/foods10123128","article-title":"Amyotrophic lateral sclerosis: a diet review","volume":"10","author":"D\u2019antona","year":"2021","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.neurol.2023.01.731_bib0200","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-022-02617-1","article-title":"Fasciculation intensity and limb dominance in amyotrophic lateral sclerosis: a muscle ultrasonographic study","volume":"22","author":"Suzuki","year":"2022","journal-title":"BMC Neurol"},{"issue":"9934","key":"10.1016\/j.neurol.2023.01.731_bib0205","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0140-6736(14)60270-1","article-title":"High-calorie diets in amyotrophic lateral sclerosis","volume":"383","author":"Al-Chalabi","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.neurol.2023.01.731_bib0210","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archneurol.2012.254","article-title":"Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review","volume":"69","author":"Costa","year":"2012","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2023.01.731_bib0220","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jnnp-2021-328331","article-title":"Fat-rich versus carbohydrate-rich nutrition in ALS: a randomised controlled study","volume":"93","author":"Dorst","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9934","key":"10.1016\/j.neurol.2023.01.731_bib0215","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(14)60222-1","article-title":"Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"383","author":"Wills","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neurol.2023.01.731_bib0225","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.25661","article-title":"Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis","volume":"87","author":"Ludolph","year":"2020","journal-title":"Ann Neurol"},{"issue":"7\u20138","key":"10.1016\/j.neurol.2023.01.731_bib0230","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/21678421.2013.823999","article-title":"High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study","volume":"14","author":"Dorst","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.neurol.2023.01.731_bib0235","volume":"7","author":"Impellizzeri","year":"2012"},{"key":"10.1016\/j.neurol.2023.01.731_bib0240","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of Observational studies in epidemiology a proposal for reporting because of pressure for timely [Internet]. Available from: http:\/\/www.wesleyan.edu."}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723009827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723009827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:47:11Z","timestamp":1758520031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378723009827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0035378723009827"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2023.01.731","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety and tolerability of high caloric diet in amyotrophic lateral sclerosis patients: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2023.01.731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}